C-EDGE treatment experienced: Effect of 12 week oral regimens of Elbasvir and Grazoprevir on health related quality of life in prior treatment experienced patients with chronic hepatitis C infection
2019 ◽
Vol 70
(1)
◽
pp. e208-e209
◽
2019 ◽
2016 ◽
Vol 24
(2)
◽
pp. 68-78
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2006 ◽
Vol 40
(6)
◽
pp. 528-534
◽
Keyword(s):